VA
HELP

Verdad Advisers’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Verdad Advisers’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$122K Buy
+18,500
New +$92.5K 0.12% 177

Other funds holding HELP

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return

Verdad Advisers's HELP Position: Q2 2026 in Review

Verdad Advisers opened a new position in Helus Pharma Inc. Common Stock (HELP) in Q2 2026: 18,500 shares worth $122K. The stake represents 0.12% of the portfolio and ranks #177 among its holdings.

99 funds tracked by Wall St. Rank hold HELP as of Q2 2026.

  • Verdad Advisers held 18,500 shares of Helus Pharma Inc. Common Stock worth $122K as of Q2 2026.
  • Helus Pharma Inc. Common Stock was a new Verdad Advisers position in Q2 2026.
  • Helus Pharma Inc. Common Stock made up 0.12% of Verdad Advisers's portfolio in Q2 2026, its #177 holding.
  • 99 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q2 2026.

Based on Verdad Advisers's 13F filing for Q2 2026, filed 14 Aug 2026.